Clinical Trial: Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts

U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07307131) titled 'Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts' on Dec. 14.

Brief Summary: This study compares the effectiveness and safety of two different intralesional treatments for cutaneous warts: a combination of furosemide and digoxin versus polidocanol.

Study Start Date: Sept. 01, 2024

Study Type: INTERVENTIONAL

Condition: Cutaneous Warts, Human Papillomavirus (HPV)

Intervention: DRUG: Intralesional combined furosemide (10 mg/ml) and digoxin (0.25 mg/ml)

Group A (Experimental): Intralesional combined furosemide (10 mg/ml) and digoxin (0.25 mg/ml)

DRUG: Intralesional polidocanol 2%

Group B (Active Comparator): Intralesional...